Thermomechanical behavior and force modulation of Shape Memory Polymer-Based Orthodontic Aligners: a material-driven biomechanical perspective

Background Conventional clear aligner therapy predominantly relies on thermoformed thermoplastic polymers whose viscoelastic behavior may lead to significant stress relaxation and force decay under intraoral conditions. Shape memory polymer (SMP)-based aligners have been proposed as thermomechanically active systems capable of partial shape recovery and force reactivation. Methods This narrative review analyzes the molecular architecture, thermomechanical cycle, viscoelastic response, and force modulation mechanisms of SMP-based orthodontic aligners. Their behavior is compared with conventional thermoformed aligners and superelastic nickel-titanium archwires from a materials perspective. Results SMP aligners combine viscoelastic relaxation with entropy-driven recovery mechanisms governed by temperature-dependent segmental mobility near the glass transition temperature (Tg). Reported Tg values range from approximately 32-45 °C in moderate-Tg systems to >50-60 °C in externally activated systems. Experimental studies have reported shape recovery exceeding 50% within 1 min at 37 °C and reaching 90% within 10 min under controlled activation. Reported force magnitudes range from 0.73 to 1.69 N, while 24-hour force loss has been reported at approximately 10-20% for SMP-based aligners compared with 30–60% for conventional thermoformed systems. These findings suggest improved force continuity and reactivation potential, although current evidence remains predominantly derived from in vitro investigations. Conclusions SMP-based aligners introduce a promising material-driven biomechanical concept based on thermomechanical coupling and partial stress recovery. However, robust clinical validation remains lacking, and in vitro mechanical advantages should not be directly extrapolated to superior clinical efficacy or treatment efficiency. Standardized thermomechanical testing and prospective clinical trials are required to determine their translational relevance.